Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials

Multiple sclerosis (MS) is a chronic illness involving the central nervous system (CNS) that is characterised by inflammation, demyelination, and degenerative changes. Dalfampridine is one of the available tre...

Source: Orphanet Journal of Rare Diseases - February 15, 2021 Category: Internal Medicine Authors: Enyao Zhang, Xin Tian, Ruoming Li, Chaoyang Chen, Min Li, Lingyun Ma, Ran Wei, Ying Zhou and Yimin Cui Tags: Review Source Type: research